Does EMPAGLIFLOZIN Cause Interstitial lung disease? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Interstitial lung disease have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 0.1% of all adverse event reports for EMPAGLIFLOZIN.
21
Reports of Interstitial lung disease with EMPAGLIFLOZIN
0.1%
of all EMPAGLIFLOZIN reports
1
Deaths
10
Hospitalizations
How Dangerous Is Interstitial lung disease From EMPAGLIFLOZIN?
Of the 21 reports, 1 (4.8%) resulted in death, 10 (47.6%) required hospitalization, and 1 (4.8%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does EMPAGLIFLOZIN Cause?
Diabetic ketoacidosis (3,644)
Fungal infection (1,941)
Blood glucose increased (1,797)
Euglycaemic diabetic ketoacidosis (1,769)
Weight decreased (1,661)
Urinary tract infection (1,439)
Ketoacidosis (1,411)
Dizziness (1,372)
Nausea (1,333)
Vomiting (1,201)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which EMPAGLIFLOZIN Alternatives Have Lower Interstitial lung disease Risk?
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN
EMPAGLIFLOZIN vs EMSAM
EMPAGLIFLOZIN vs EMTRICITABINE